Investing.com - Financial Markets Worldwide

InventisBio Co Ltd (688382)

Shanghai
Currency in CNY
39.80
-2.26(-5.37%)
Closed·
688382 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
688382 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
39.4742.30
52 wk Range
6.6749.68
Key Statistics
Edit
Bid/Ask
39.79 / 39.80
Prev. Close
42.06
Open
42.02
Day's Range
39.47-42.3
52 wk Range
6.67-49.68
Volume
20.3M
Average Volume (3m)
13.4M
1-Year Change
414.88%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688382 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Strong Buy
Price Target
28.50
Downside
-28.39%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 15
Stock has taken a big hit over the last week
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

InventisBio Co Ltd Company Profile

InventisBio Co., Limited, a clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States. The company’s drug candidates for the oncology therapeutic area include BPI-D0316, which is in Phase III clinical trial for the non-small cell lung cancer (NSCLS) indications; D-0502, which is in Phase I clinical trial for the breast cancer indications; and D-1553, which in Phase I clinical trial for NSCLS, colorectal cancer indications. Its drug candidates for the metabolic therapeutic area is D-0120, a Phase I and II clinical trial product for hyperuricemia and gout indications. The company has a collaboration agreement with Betta Pharmaceuticals. InventisBio Co., Limited was founded in 2013 and is headquartered in Pudong, China.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
185
Market
China

Compare 688382 to Peers and Sector

Metrics to compare
688382
Peers
Sector
Relationship
P/E Ratio
−107.3x−20.3x−0.5x
PEG Ratio
−8.090.300.00
Price/Book
13.0x7.1x2.6x
Price / LTM Sales
136.7x18.5x3.3x
Upside (Analyst Target)
−28.4%0.0%43.5%
Fair Value Upside
Unlock−18.6%6.8%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 28.50
(-28.39% Downside)

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
-0.10 / --
Revenue / Forecast
8.19M / --
EPS Revisions
a
a
Unlock
Last 90 days

688382 Income Statement

FAQ

What Stock Exchange Does InventisBio Trade On?

InventisBio is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for InventisBio?

The stock symbol for InventisBio is "688382."

What Is the InventisBio Market Cap?

As of today, InventisBio market cap is 23.02B.

What Is InventisBio's Earnings Per Share (TTM)?

The InventisBio EPS (TTM) is -0.38.

When Is the Next InventisBio Earnings Date?

InventisBio will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is 688382 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has InventisBio Stock Split?

InventisBio has split 0 times.

How Many Employees Does InventisBio Have?

InventisBio has 185 employees.

What is the current trading status of InventisBio (688382)?

As of 09 Aug 2025, InventisBio (688382) is trading at a price of 39.80, with a previous close of 42.06. The stock has fluctuated within a day range of 39.47 to 42.30, while its 52-week range spans from 6.67 to 49.68.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.